Inventor · disambiguated record
Richard Soltero
Also filed as: SOLTERO RICHARD · SOLTERO RICHARD A
13 granted patents·9 pending applications·209 citations·filing 2001–2024
92Inventor score
Files withBIOCON LTD6NOBEX CORP4OREXIGEN THERAPEUTICS INC4NALPROPION PHARMACEUTICALS LLC3SOLTERO RICHARD A2
Top patents by PatentIndex Score
22 records- 0195US12048769B2Methods for administering weight loss medicationsNALPROPION PHARMACEUTICALS LLC·Filed 2020·Granted Jul 30, 2024·3 cites·20 claims
- 0294US9107837B2Sustained release formulation of naltrexoneOREXIGEN THERAPEUTICS INC·Filed 2014·Granted Aug 18, 2015·13 cites·17 claims
- 0392US8916195B2Sustained release formulation of naltrexoneMCKINNEY ANTHONY A·Filed 2007·Granted Dec 23, 2014·23 cites·15 claims
- 0490US7030082B2Pharmaceutical compositions of drug-oligomer conjugates and methods of treating disease therewithNOBEX CORP·Filed 2003·Granted Apr 18, 2006·38 cites·72 claims
- 0590US6867183B2Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewithNOBEX CORP·Filed 2002·Granted Mar 15, 2005·47 cites·133 claims
- 0689US6770625B2Pharmaceutical compositions of calcitonin drug-oligomer conjugates and methods of treating diseases therewithNOBEX CORP·Filed 2002·Granted Aug 3, 2004·49 cites·130 claims
- 0788US6913903B2Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing sameNOBEX CORP·Filed 2001·Granted Jul 5, 2005·14 cites·115 claims
- 0886US2024366513A1Methods For Administering Weight Loss MedicationsNALPROPION PHARMACEUTICALS LLC·Filed 2024·Application pending·0 cites
- 0984US2023301922A1Layered Pharmaceutical FormulationsNALPROPION PHARMACEUTICALS LLC·Filed 2023·Application pending·0 cites
- 1078US7196059B2Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewithBIOCON LTD·Filed 2003·Granted Mar 27, 2007·9 cites·34 claims
- 1177US7166571B2Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing sameBIOCON LTD·Filed 2003·Granted Jan 23, 2007·6 cites·132 claims
- 1272US2019183883A1Sustained Release Formulation Of NaltrexoneNALPROPION PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1369US7635675B2Micro-particle fatty acid salt solid dosage formulations for therapeutic agentsBIOCON LTD·Filed 2004·Granted Dec 22, 2009·5 cites·24 claims
- 1467US7611864B2Proinsulin polypeptide-oligomer conjugatesBIOCON LTD·Filed 2004·Granted Nov 3, 2009·0 cites·8 claims
- 1565US2017014404A1Sustained release formulation of naltrexoneOREXIGEN THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 1663US2016158225A1Sustained release formulation of naltrexoneOREXIGEN THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 1762US2016158221A1Sustained release formulation of naltrexoneOREXIGEN THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 1861US7312192B2Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing sameBIOCON LTD·Filed 2003·Granted Dec 25, 2007·2 cites·137 claims
- 1959US7368260B2Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing sameBIOCON LTD·Filed 2005·Granted May 6, 2008·0 cites·45 claims
- 2057US2008226705A1Gel delivery system for oral administration of medicamentsSOLTERO RICHARD A·Filed 2008·Application pending·0 cites
- 2155US2008097804A1System and method for developing and managing a manufacturing processSOLTERO RICHARD A·Filed 2007·Application pending·0 cites
- 2249US2007196495A1Method for administering medicaments to subjects with swallowing difficulties and disordersSOLTERO RICHARD·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Richard Soltero files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →